
Croise-SB 1.5 Injection
Marketer
Croise Pharma
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Croise-SB 1.5 Injection
Combiflox-1.5 Injection is a dual-action antibiotic, indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, hindering infection spread. Administration must be solely under a doctor's guidance; adhere strictly to the prescribed schedule. Complete the full treatment course, regardless of symptom improvement; premature cessation may compromise efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia; consult your physician if these worsen. Seek immediate medical attention for allergic reactions (rash, itching, edema, dyspnea). Inform your doctor of all concurrent medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving, refrain if experiencing somnolence or dizziness. Ensure adequate rest, nutrition, and hydration for optimal recovery. Your doctor may order blood tests and imaging to monitor treatment response.
Uses of Croise-SB 1.5 Injection
Infections caused by bacteria
Major Benefits of Croise-SB 1.5 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Croise-SB 1.5 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Croise-SB 1.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Croise-SB 1.5 Injection works:
Ceftriaxone and Sulbactam, the active components of Croise-SB 1.5 Injection, act synergistically. Ceftriaxone, a third-generation cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus optimizing Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Croise-SB 1.5 Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Croise-SB 1.5 Injection is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Croise-SB 1.5 Injection to breastfeeding mothers requires careful consideration. Mothers should temporarily discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.
DrivingUNSAFE
Croise-SB 1.5 Injection can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding Croise-SB 1.5 Injection's use in individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
Exercise caution when administering Croise-SB 1.5 Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Croise-SB 1.5 Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Croise-SB 1.5 Injection :
Omitting a scheduled dose of Croise-SB 1.5 Injection necessitates contacting your physician.
Facts to Know About Croise-SB 1.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
